This country profile provides an overview of Botswana’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
29%
Bilharzia
NR
River blindness
N/A
0.07 million people received treatment in Botswana in 2017 0.19 million people did not receive treatment in Botswana in 2017

Priorities for progress in Botswana

  • Botswana is commended for its leadership and commitment to address treatment gaps in NTDs, as demonstrated by the recent announcement by the Government to fully fund the national NTD programme with its own domestic resources from 2019.
  • Botswana is encouraged to work with WHO AFRO for technical support in mapping bilharzia and to increase the coverage for both this disease and intestinal worms.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Botswana does not require mass treatment for elephantiasis.

Blinding trachoma

Botswana does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage remained the same at 29% in 2016 and 2017.

Pre-sch and school-aged children needing treatment
0.24m
Pre-school and school-aged children receiving treatment
0.07m

Bilharzia

Treatment coverage was not reported in 2016 and 2017.

School-aged children needing treatment
0.15m
School-aged children receiving treatment
Not reported

River blindness

Botswana does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Botswana.